The Scotts Miracle-Gro Company (SMG) Reaches $108.01 52-Week High; Rock Springs Capital Management LP Increased Five Prime Therapeutics (FPRX) Stake By $828,000

January 14, 2018 - By Vivian Park

The stock of The Scotts Miracle-Gro Company (NYSE:SMG) hit a new 52-week high and has $116.65 target or 8.00% above today’s $108.01 share price. The 6 months bullish chart indicates low risk for the $6.21 billion company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $116.65 price target is reached, the company will be worth $496.40M more. The stock decreased 1.33% or $1.46 during the last trading session, reaching $108.01. About 338,576 shares traded. The Scotts Miracle-Gro Company (NYSE:SMG) has risen 31.99% since January 14, 2017 and is uptrending. It has outperformed by 15.29% the S&P500.

Rock Springs Capital Management Lp increased Five Prime Therapeutics Inc (FPRX) stake by 10.51% reported in 2017Q3 SEC filing. Rock Springs Capital Management Lp acquired 20,700 shares as Five Prime Therapeutics Inc (FPRX)’s stock declined 39.09%. The Rock Springs Capital Management Lp holds 217,700 shares with $8.91 million value, up from 197,000 last quarter. Five Prime Therapeutics Inc now has $613.03M valuation. The stock decreased 2.62% or $0.57 during the last trading session, reaching $21.19. About 442,788 shares traded. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) has declined 30.56% since January 14, 2017 and is downtrending. It has underperformed by 47.26% the S&P500.

Analysts await The Scotts Miracle-Gro Company (NYSE:SMG) to report earnings on January, 30. They expect $-0.94 earnings per share, up 2.08% or $0.02 from last year’s $-0.96 per share. After $-0.26 actual earnings per share reported by The Scotts Miracle-Gro Company for the previous quarter, Wall Street now forecasts 261.54% negative EPS growth.

The Scotts Miracle-Gro Company manufactures, markets, and sells consumer lawn and garden products worldwide. The company has market cap of $6.21 billion. The Company’s Lawn Care segment offers lawn fertilizers, grass seed products, spreaders, other durable products, and outdoor cleaners, as well as lawn-related weed, pest, and disease control products. It has a 29.75 P/E ratio. The companyÂ’s Gardening and Landscape segment provides water soluble and continuous-release plant foods, potting mixes and garden soils, mulch and decorative groundcover products, plant-related pest and disease control products, organic garden products, live goods and seeding solutions, and hydroponic gardening products.

Investors sentiment decreased to 0.94 in Q3 2017. Its down 0.30, from 1.24 in 2017Q2. It fall, as 33 investors sold The Scotts Miracle-Gro Company shares while 103 reduced holdings. 39 funds opened positions while 89 raised stakes. 38.40 million shares or 1.70% less from 39.06 million shares in 2017Q2 were reported. Moreover, Loring Wolcott & Coolidge Fiduciary Advisors Llp Ma has 0% invested in The Scotts Miracle-Gro Company (NYSE:SMG) for 12 shares. Profund Advsr Limited Liability Com reported 6,064 shares. Millennium Ltd Liability Corporation, New York-based fund reported 70,413 shares. Pub Employees Retirement Sys Of Ohio invested in 21,433 shares. Lazard Asset Mgmt Limited Liability Com reported 84,024 shares. Moreover, Ameriprise Fincl Inc has 0.01% invested in The Scotts Miracle-Gro Company (NYSE:SMG). Principal Fincl Grp Inc owns 175,317 shares or 0.02% of their US portfolio. Natixis Asset Management stated it has 14,790 shares or 0.12% of all its holdings. 50,531 were reported by Invesco Limited. Da Davidson holds 0.02% or 9,410 shares. Teacher Retirement System Of Texas owns 3,687 shares. Fdx Advsrs Inc holds 0.01% or 5,597 shares. Congress Asset Management Ma reported 8,967 shares. Alpha Cubed Limited Company has invested 0.35% in The Scotts Miracle-Gro Company (NYSE:SMG). Credit Agricole S A holds 17,848 shares or 0.01% of its portfolio.

Since July 31, 2017, it had 0 insider buys, and 12 sales for $25.86 million activity. Another trade for 16,000 shares valued at $1.51 million was made by Hagedorn Partnership – L.P. on Friday, September 8. HAGEDORN JAMES also sold $8.90 million worth of The Scotts Miracle-Gro Company (NYSE:SMG) shares. Johnson Michelle A also sold $45,308 worth of The Scotts Miracle-Gro Company (NYSE:SMG) on Monday, August 14. 5,000 shares were sold by Mistretta Nancy G., worth $500,551. $1.34M worth of The Scotts Miracle-Gro Company (NYSE:SMG) was sold by Coleman Thomas Randal on Tuesday, August 8. HAGEDORN SUSAN sold $1.51M worth of stock or 16,000 shares. $1.51 million worth of stock was sold by HAGEDORN PAUL on Friday, September 8.

Among 7 analysts covering Scotts Miracle-Gro Company (The) (NYSE:SMG), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Scotts Miracle-Gro Company (The) had 12 analyst reports since March 22, 2016 according to SRatingsIntel. Gabelli initiated The Scotts Miracle-Gro Company (NYSE:SMG) on Thursday, October 20 with “Buy” rating. KeyBanc Capital Markets maintained the stock with “Hold” rating in Wednesday, November 22 report. The stock of The Scotts Miracle-Gro Company (NYSE:SMG) earned “Buy” rating by Bank of America on Wednesday, November 8. The rating was downgraded by SunTrust to “Hold” on Wednesday, January 11. JP Morgan downgraded the shares of SMG in report on Wednesday, November 8 to “Neutral” rating. The rating was downgraded by Suntrust Robinson on Wednesday, January 11 to “Hold”. KeyBanc Capital Markets maintained the stock with “Hold” rating in Monday, August 28 report. The stock of The Scotts Miracle-Gro Company (NYSE:SMG) earned “Overweight” rating by JP Morgan on Thursday, August 4. The firm earned “Neutral” rating on Tuesday, March 22 by JP Morgan. The company was downgraded on Wednesday, November 8 by J.P. Morgan.

Among 10 analysts covering Five Prime Therapeutics (NASDAQ:FPRX), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Five Prime Therapeutics had 21 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) earned “Sell” rating by Zacks on Friday, August 21. The firm has “Sell” rating given on Tuesday, August 11 by Zacks. The company was maintained on Tuesday, November 7 by BMO Capital Markets. The firm has “Buy” rating by Jefferies given on Monday, September 11. The rating was maintained by Oppenheimer with “Outperform” on Monday, October 19. Citigroup initiated Five Prime Therapeutics, Inc. (NASDAQ:FPRX) on Friday, July 31 with “Buy” rating. On Tuesday, October 25 the stock rating was initiated by Citigroup with “Buy”. The stock of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) earned “Buy” rating by RBC Capital Markets on Monday, November 6. The stock has “Hold” rating by BMO Capital Markets on Wednesday, September 20. As per Friday, March 11, the company rating was maintained by Credit Suisse.

Rock Springs Capital Management Lp decreased Madrigal Pharmaceuticals Inc stake by 265,000 shares to 275,000 valued at $12.37M in 2017Q3. It also reduced Galapagos Nv stake by 7,500 shares and now owns 214,000 shares. Advanced Accelerator Applic was reduced too.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.34, from 0.7 in 2017Q2. It improved, as 14 investors sold FPRX shares while 34 reduced holdings. 18 funds opened positions while 32 raised stakes. 23.96 million shares or 0.77% more from 23.78 million shares in 2017Q2 were reported. Swiss Natl Bank has invested 0% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Nationwide Fund Advsr holds 0.01% or 70,059 shares in its portfolio. Maryland-based Proshare Advsr Ltd Liability has invested 0.01% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). 322,284 are held by Northern Tru. Morgan Stanley holds 0% or 53,267 shares in its portfolio. Artal Gp Sa has invested 0.04% of its portfolio in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Alps Advsrs holds 28,330 shares or 0.01% of its portfolio. Sei Investments Communications owns 16 shares. Ameritas Ptnrs reported 2,330 shares or 0% of all its holdings. Art Advsr Lc holds 24,974 shares. Adage Partners Gru Limited Company accumulated 2.43M shares. Legal And General Gru Public Limited Co has 10,281 shares. Assetmark has invested 0% in Five Prime Therapeutics, Inc. (NASDAQ:FPRX). Platinum Management Ltd reported 20,800 shares or 0.02% of all its holdings. Guggenheim Capital Limited Liability Com holds 0.01% of its portfolio in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) for 68,636 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>